Werner Claudia G, Godfrey Virginia, Arnold Roland R, Featherstone Gerald L, Bender Diane, Schlossmann Jens, Schiemann Matthias, Hofmann Franz, Pryzwansky Katherine B
Institut für Pharmakologie und Toxikologie, Technische Universität München, München, Germany.
J Immunol. 2005 Aug 1;175(3):1919-29. doi: 10.4049/jimmunol.175.3.1919.
The regulation of neutrophil functions by Type I cGMP-dependent protein kinase (cGKI) was investigated in wild-type (WT) and cGKI-deficient (cGKI-/-) mice. We demonstrate that murine neutrophils expressed cGKIalpha. Similar to the regulation of Ca2+ by cGKI in other cells, there was a cGMP-dependent decrease in Ca2+ transients in response to C5a in WT, but not cGKI-/- bone marrow neutrophils. In vitro chemotaxis of bone marrow neutrophils to C5a or IL-8 was significantly greater in cGKI-/- than in WT. Enhanced chemotaxis was also observed with cGKI-/- peritoneal exudate neutrophils (PE-N). In vivo chemotaxis with an arachidonic acid-induced inflammatory ear model revealed an increase in both ear weight and myeloperoxidase (MPO) activity in ear punches of cGKI-/- vs WT mice. These changes were attributable to enhanced vascular permeability and increased neutrophil infiltration. The total extractable content of MPO, but not lysozyme, was significantly greater in cGKI-/- than in WT PE-N. Furthermore, the percentage of MPO released in response to fMLP from cGKI-/- (69%) was greater than that from WT PE-N (36%). PMA failed to induce MPO release from PE-N of either genotype. In contrast, fMLP and PMA released equivalent amounts of lysozyme from PE-N. However, the percentage released was less in cGKI-/- (approximately 60%) than in WT (approximately 90%) PE-N. Superoxide release (maximum velocity) revealed no genotype differences in responses to PMA or fMLP stimulation. In summary, these results show that cGKIalpha down-regulates Ca2+ transients and chemotaxis in murine neutrophils. The regulatory influences of cGKIalpha on the secretagogue responses are complex, depending on the granule subtype.
在野生型(WT)和cGKI基因缺陷型(cGKI-/-)小鼠中研究了I型环鸟苷酸依赖性蛋白激酶(cGKI)对中性粒细胞功能的调节作用。我们证明小鼠中性粒细胞表达cGKIα。与cGKI在其他细胞中对Ca2+的调节类似,野生型骨髓中性粒细胞对C5a的反应中,Ca2+瞬变呈cGMP依赖性降低,但cGKI-/-骨髓中性粒细胞则不然。cGKI-/-骨髓中性粒细胞对C5a或IL-8的体外趋化作用显著大于野生型。cGKI-/-腹膜渗出液中性粒细胞(PE-N)也观察到趋化作用增强。在花生四烯酸诱导的炎症耳部模型中进行的体内趋化作用显示,与野生型小鼠相比,cGKI-/-小鼠耳部打孔后的耳部重量和髓过氧化物酶(MPO)活性均增加。这些变化归因于血管通透性增强和中性粒细胞浸润增加。cGKI-/- PE-N中MPO的总可提取含量显著高于野生型,但溶菌酶含量无显著差异。此外,cGKI-/-(69%)对fMLP反应释放的MPO百分比高于野生型PE-N(36%)。佛波酯(PMA)未能诱导两种基因型PE-N释放MPO。相反,fMLP和PMA从PE-N释放等量的溶菌酶。然而,cGKI-/-(约60%)释放的百分比低于野生型(约90%)PE-N。超氧化物释放(最大速度)显示对PMA或fMLP刺激的反应无基因型差异。总之,这些结果表明cGKIα下调小鼠中性粒细胞中的Ca2+瞬变和趋化作用。cGKIα对促分泌剂反应的调节影响是复杂的,取决于颗粒亚型。